C.M. Bidwell & Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$233K Sell
4,761
-29
-0.6% -$1.35K 0.11% 123
2025
Q4
$209K Sell
4,790
-155
-3% -$7.07K 0.1% 131
2025
Q3
$223K Sell
4,945
-313
-6% -$13.7K 0.11% 120
2025
Q2
$228K Sell
5,258
-262
-5% -$11.7K 0.12% 119
2025
Q1
$254K Sell
5,520
-155
-3% -$6.48K 0.15% 102
2024
Q4
$214K Sell
5,675
-130
-2% -$5.04K 0.13% 115
2024
Q3
$235K Buy
+5,805
New +$218K 0.14% 106
2022
Q4
Sell
-2,356
Closed -$88K 511
2022
Q3
$88K Hold
2,356
0.07% 227
2022
Q2
$107K Sell
2,356
-7
-0.3% -$329 0.08% 208
2022
Q1
$113K Sell
2,363
-1,076
-31% -$45.6K 0.07% 223
2021
Q4
$142K Sell
3,439
-24
-0.7% -$904 0.09% 211
2021
Q3
$119K Hold
3,463
0.08% 230
2021
Q2
$109K Buy
3,463
+80
+2% +$2.58K 0.07% 242
2021
Q1
$106K Buy
+3,383
New +$102K 0.08% 234
2017
Q2
Sell
-145,338
Closed -$3.73M 339
2017
Q1
$3.73M Buy
+145,338
New +$3.7M 0.84% 60
2016
Q4
Sell
-9,288
Closed -$221K 257
2016
Q3
$221K Buy
9,288
+8,748
+1,620% +$220K 0.05% 152
2016
Q2
$14K Hold
540
﹤0.01% 224
2016
Q1
$14K Hold
540
﹤0.01% 233
2015
Q4
$11K Buy
+540
New +$10.9K ﹤0.01% 221
2014
Q4
Sell
-91,130
Closed -$2.22M 222
2014
Q3
$2.22M Hold
91,130
0.52% 83
2014
Q2
$2.37M Hold
91,130
0.54% 87
2014
Q1
$2.18M Sell
91,130
-140
-0.2% -$2.95K 0.52% 83
2013
Q4
$1.78M Sell
91,270
-330
-0.4% -$6.64K 0.44% 84
2013
Q3
$1.94M Sell
91,600
-203
-0.2% -$4.44K 0.53% 87
2013
Q2
$2.02M Buy
+91,803
New +$2.23M 0.59% 81

Other funds holding EXC

C.M. Bidwell & Associates's EXC Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its Exelon (EXC) stake by 0.61% in Q1 2026, selling an estimated $1.35K and leaving 4,761 shares worth $233K. The position accounts for 0.11% of the portfolio, ranked #123.

C.M. Bidwell & Associates first reported a position in EXC in Q2 2013 and has held it in 25 quarters since. The position peaked at $3.73M in Q1 2017. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • C.M. Bidwell & Associates held 4,761 shares of Exelon worth $233K as of Q1 2026.
  • C.M. Bidwell & Associates sold 29 Exelon shares in Q1 2026, an estimated $1.35K.
  • Exelon made up 0.11% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #123 holding.
  • C.M. Bidwell & Associates first reported a position in Exelon in Q2 2013 and has held it in 25 quarters since.
  • C.M. Bidwell & Associates's Exelon position peaked at $3.73M in Q1 2017.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.